BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Dexcom Further Advances Vision of Glucose Biosensing for All

  June 24, 2026

   · 

  4 min read
• Press Releases

  Vyriad Announces Strategic Leadership Changes to Drive Next Phase of Growth

  June 24, 2026

   · 

  3 min read
• Press Releases

  Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies

  June 24, 2026

   · 

  3 min read
• Press Releases

  FDA Approves the HepQuant SHUNT® Liver Diagnostic Test to Quantify Risk of Large Esophageal Varices in Adult Patients with Compensated Cirrhosis (Child Pugh Class A)

  June 24, 2026

   · 

  5 min read
• Press Releases

  Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies

  June 24, 2026

   · 

  4 min read
• Press Releases

  Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

  June 24, 2026

   · 

  4 min read
• Press Releases

  HighRes® and Waters Collaborate to Advance Drug Discovery through Robotic Automation

  June 24, 2026

   · 

  2 min read
• Press Releases

  Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs

  June 24, 2026

   · 

  3 min read
• Press Releases

  ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics

  June 24, 2026

   · 

  3 min read
• Press Releases

  GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma

  June 24, 2026

   · 

  9 min read